Research in haematological cancers: What do patients in the Netherlands prioritise?

Anne Floor M. Schölvinck*, Bert M.B. de Graaff, Mechteld J. van den Beld, Jacqueline E.W. Broerse

*Corresponding author for this work

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Introduction: The experiential knowledge of patients can provide research communities with complementary perspectives on disease. The aim of this study was to identify and prioritise everyday problems and research needs of haematological cancer patients and people who have undergone a stem cell transplantation. Methods: A mixed-method participatory research approach (the Dialogue Model) was applied, including interviews (n = 19), four focus group discussions (n = 27), a questionnaire (n = 146) and a stakeholder dialogue meeting (n = 30) with patients in the Netherlands. Results: Patients’ physical discomfort, psychosocial issues, problems with the healthcare system and policy issues were highlighted. Respondents prioritise research aimed at factors potentially influencing survival, such as lifestyle, and research aimed at improving patients’ quality of life, for example improving memory and concentration problems. Topics also focused on physical discomfort, causal mechanisms, and healthcare organisation and policies. Research of a social scientific character is underrepresented, and as such, patients’ everyday problems are not all directly reflected in the research agenda. Conclusions: Our findings indicate that patients, besides emphasising the importance of improving survival, have a clear desire to increase control over their lives.

Original languageEnglish
Article numbere12989
Pages (from-to)1-14
Number of pages14
JournalEuropean Journal of Cancer Care
Volume28
Issue number2
Early online date23 Jan 2019
DOIs
Publication statusPublished - Mar 2019

Keywords

  • haematological cancers
  • patient involvement
  • research agenda

Fingerprint

Dive into the research topics of 'Research in haematological cancers: What do patients in the Netherlands prioritise?'. Together they form a unique fingerprint.

Cite this